Matteo Bellone
Matteo Bellone
Unknown affiliation
Verified email at - Homepage
TitleCited byYear
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines
A Ronchetti, P Rovere, G Iezzi, G Galati, S Heltai, MP Protti, MP Garancini, ...
The Journal of Immunology 163 (1), 130-136, 1999
Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
S Manici, T Sturniolo, MA Imro, J Hammer, F Sinigaglia, C Noppen, ...
Journal of Experimental Medicine 189 (5), 871-876, 1999
Processing of engulfed apoptotic bodies yields T cell epitopes.
M Bellone, G Iezzi, P Rovere, G Galati, A Ronchetti, MP Protti, J Davoust, ...
The Journal of Immunology 159 (11), 5391-5399, 1997
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes
A Calcinotto, P Filipazzi, M Grioni, M Iero, A De Milito, A Ricupito, A Cova, ...
Cancer research 72 (11), 2746-2756, 2012
Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response
F Cavallo, A Martin‐Fontecha, M Bellone, S Heltai, E Gatti, P Tornaghi, ...
European journal of immunology 25 (5), 1154-1162, 1995
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
M Bellone, D Cantarella, P Castiglioni, MC Crosti, A Ronchetti, M Moro, ...
The Journal of Immunology 165 (5), 2651-2656, 2000
Myasthenia gravis: recognition of a human autoantigen at the molecular level
MP Protti, AA Manfredi, RM Horton, M Bellone, BM Conti-Tronconi
Immunology today 14 (7), 363-368, 1993
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes
A Camporeale, A Boni, G Iezzi, E Degl’Innocenti, M Grioni, A Mondino, ...
Cancer Research 63 (13), 3688-3694, 2003
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy
A Calcinotto, M Grioni, E Jachetti, F Curnis, A Mondino, G Parmiani, ...
The Journal of Immunology 188 (6), 2687-2694, 2012
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization
E Degl'Innocenti, M Grioni, A Boni, A Camporeale, MTS Bertilaccio, ...
European journal of immunology 35 (1), 66-75, 2005
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation
M Esposito, F Ruffini, M Bellone, N Gagliani, M Battaglia, G Martino, ...
Journal of neuroimmunology 220 (1-2), 52-63, 2010
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+ CD25+ regulatory T cells
E Degl'Innocenti, M Grioni, G Capuano, E Jachetti, M Freschi, ...
Cancer research 68 (1), 292-300, 2008
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
M Bellone, A Calcinotto
Frontiers in oncology 3, 231, 2013
The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic …
M Bellone, N Ostlie, SJ Lei, XD Wu, BM Conti-Tronconi
The Journal of Immunology 147 (5), 1484-1491, 1991
Crucial role for interferon γ in the synergism between tumor vasculature-targeted tumor necrosis factor α (NGR-TNF) and doxorubicin
A Sacchi, A Gasparri, F Curnis, M Bellone, A Corti
Cancer research 64 (19), 7150-7155, 2004
Heterogeneous effects of B7‐1 and B7‐2 in the induction of both protective and therapeutic anti‐tumor immunity against different mouse tumors
A Martin‐Fontecha, F Cavallo, M Bellone, S Heltai, G Iezzi, P Tornaghi, ...
European journal of immunology 26 (8), 1851-1859, 1996
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen‐presenting cells
M Bellone, G Iezzi, AA Manfredi, MP Protti, P Dellabona, G Casorati, ...
European journal of immunology 24 (11), 2691-2698, 1994
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
M Bellone, A Calcinotto, P Filipazzi, A De Milito, S Fais, L Rivoltini
Oncoimmunology 2 (1), e22058, 2013
Experimental myasthenia gravis in congenic mice. Sequence mapping and H‐2 restriction of T helper epitopes on the α subunits of Torpedo californica and murine …
M Bellone, N Ostlie, S Lei, BM Conti‐Tronconi
European journal of immunology 21 (10), 2303-2310, 1991
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells
M Bellone, M Ceccon, M Grioni, E Jachetti, A Calcinotto, A Napolitano, ...
PloS one 5 (1), e8646, 2010
The system can't perform the operation now. Try again later.
Articles 1–20